News from us and our partners

Tags

Topics

0 results

News
4 July, 2023
Simon Turner talks digital medicine at LSI USA '23
News
28 June, 2023
Maestro, Moon Surgical's rising star
News
26 June, 2023
May Health announces data from feasibility studies of its novel Ovarian Rebalancing™ treatment and receives approval from FDA for pivotal trial
News
21 June, 2023
Noema Pharma appoints Ilise Lombardo, M.D., as Chief Executive Officer
News
20 June, 2023
CorWave announces second closing of its Series C funding at €61M to finance its first industrial deployment
News
20 June, 2023
Nuage Therapeutics raises €12M in seed financing, led by Sofinnova Partners and Asabys
News
15 June, 2023
F2G receives FDA complete response letter for olorofim NDA
News
8 June, 2023
Production operations at AFYREN NEOXY plant make significant progress, with first lots delivered
News
7 June, 2023
Mozart Therapeutics raises $25 million in expanded Series A financing to support clinical development of first-in-class CD8 Treg modulators for the treatment of autoimmune diseases
News
6 June, 2023
AAVantgarde closes €61 million Series A financing to advance two therapeutic programs into the clinic
News
5 June, 2023
Amolyt Pharma announces initiation of phase 1 clinical trial of peptide growth hormone receptor antagonist (GHRA), AZP-3813, for Acromegaly
News
1 June, 2023
Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology
News
31 May, 2023
BrightHeart announces €2 million in seed financing from Sofinnova Partners to improve the detection of fetal heart abnormalities
News
23 May, 2023
TISSIUM Raises €50M in Series D funding to finance its commercial launch and platform extension
News
18 May, 2023
F2G moves UK headquarters to MediaCity in Manchester
News
17 May, 2023
Moon Surgical appoints Fred Moll, MD, as Board Chair and raises additional $55.4 million in new funding with leading investors Sofinnova Partners and NVIDIA

Simon Turner talks digital medicine at LSI USA '23

Maestro, Moon Surgical's rising star

May Health announces data from feasibility studies of its novel Ovarian Rebalancing™ treatment and receives approval from FDA for pivotal trial

Noema Pharma appoints Ilise Lombardo, M.D., as Chief Executive Officer

CorWave announces second closing of its Series C funding at €61M to finance its first industrial deployment

Nuage Therapeutics raises €12M in seed financing, led by Sofinnova Partners and Asabys

F2G receives FDA complete response letter for olorofim NDA

Production operations at AFYREN NEOXY plant make significant progress, with first lots delivered

Mozart Therapeutics raises $25 million in expanded Series A financing to support clinical development of first-in-class CD8 Treg modulators for the treatment of autoimmune diseases

AAVantgarde closes €61 million Series A financing to advance two therapeutic programs into the clinic

Amolyt Pharma announces initiation of phase 1 clinical trial of peptide growth hormone receptor antagonist (GHRA), AZP-3813, for Acromegaly

Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology

BrightHeart announces €2 million in seed financing from Sofinnova Partners to improve the detection of fetal heart abnormalities

TISSIUM Raises €50M in Series D funding to finance its commercial launch and platform extension

F2G moves UK headquarters to MediaCity in Manchester

Moon Surgical appoints Fred Moll, MD, as Board Chair and raises additional $55.4 million in new funding with leading investors Sofinnova Partners and NVIDIA